Metropolitan Life Insurance Company (MetLife)’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,955
| Closed | -$95.5K | – | 1027 |
|
|
2024
Q1 | $95.5K | Sell |
2,955
-163
| -5% | -$5.27K | ﹤0.01% | 1066 |
|
|
2023
Q4 | $131K | Hold |
3,118
| – | – | 0.01% | 939 |
|
|
2023
Q3 | $120K | Buy |
3,118
+167
| +6% | +$6.41K | 0.01% | 916 |
|
|
2023
Q2 | $56K | Buy |
2,951
+585
| +25% | +$11.1K | ﹤0.01% | 1359 |
|
|
2023
Q1 | $36.7K | Sell |
2,366
-388
| -14% | -$6.02K | ﹤0.01% | 1560 |
|
|
2022
Q4 | $48.9K | Buy |
2,754
+299
| +12% | +$5.31K | ﹤0.01% | 1494 |
|
|
2022
Q3 | $13.7K | Buy |
+2,455
| New | +$13.7K | ﹤0.01% | 2193 |
|
|
2022
Q2 | – | Sell |
-2,758
| Closed | -$15.2K | – | 2399 |
|
|
2022
Q1 | $15.2K | Sell |
2,758
-1,238
| -31% | -$6.82K | ﹤0.01% | 2203 |
|
|
2021
Q4 | $34K | Sell |
3,996
-1,409
| -26% | -$12K | ﹤0.01% | 2728 |
|
|
2021
Q3 | $47K | Sell |
5,405
-6,840
| -56% | -$59.4K | ﹤0.01% | 2768 |
|
|
2021
Q2 | $129K | Buy |
12,245
+2,885
| +31% | +$30.5K | ﹤0.01% | 2450 |
|
|
2021
Q1 | $150K | Sell |
9,360
-943
| -9% | -$15.1K | ﹤0.01% | 2209 |
|
|
2020
Q4 | $476K | Hold |
10,303
| – | – | 0.01% | 1384 |
|
|
2020
Q3 | $363K | Buy |
10,303
+3,779
| +58% | +$133K | 0.01% | 1428 |
|
|
2020
Q2 | $159K | Buy |
+6,524
| New | +$159K | ﹤0.01% | 1960 |
|